research and development

Dear Research Advocate: During a visit to the University of Michigan last week, I learned about an important new initiative that empowers faculty to take a more active role in public engagement. An explicit goal is to convey the return on taxpayer investment in the university, very much including the return on research conducted there. The initiative is timely and important, designed to help address signs of public disenchantment with academia by demonstrating its relevance and accountability to the public. Kudos to U of M President Mark Schlissel for his leadership. Last week, panelists at our Capitol Hill briefing engaged on the need for increased investment in Alzheimer’s disease...
Dear Research Advocate: The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word! One hundred and sixty five university presidents and chancellors, representing all 50 states, have called on the president and Congress to reverse the pending “innovation deficit” in an open...
Dear Research Advocate: The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word! One hundred and sixty five university presidents and chancellors, representing all 50 states, have called on the president and Congress to reverse the pending “innovation deficit” in an open...
CVD 2013 student delegation at the Capitol; Photo Credit: Charles Haynes Amidst difficult budget negotiations on Capitol Hill, on March 12 and 13, MIT students and postdocs traveled to Washington to sound a warning about the future of science and engineering research in this country if indiscriminate cuts to federal programs continue. In addition to mostly flat funding in recent budgets, language in the Budget Control Act of 2012 calling for across-the-board cuts’€”known as ’€œsequestration’€’€”took effect on March 1. These cuts, in addition to the ongoing erosion of federal funding for scientific research, decrease America’€™s ability to maintain economic growth and remain globally...
President Barack Obama unveiled the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative on Tuesday. Described in a White House press release as one of the administration’€™s ’€œGrand Challenges,’€ the goal of the initiative is to bring private and public sector research together to accelerate the development and application of technology and research into the function of complex neural networks. President Obama laid the ground work for today’€™s announcement during his State of the Union address in January, calling for an increased investment in research to achieve ’€œa level of research and development not seen since the height of the space race.’€ The...
Did you know that neglected tropical diseases such as dengue, Chagas and hookworm affect over 1.4 billion people worldwide, including individuals here in the U.S.? To discuss the global burden of NTDs and how federal funding and policy decisions impact the research and development of tools to combat these diseases around the world, Research!America will be hosting a panel at the Consortium of Universities for Global Health (CUGH) conference*. The panel, ’€œAre NTDs a Growing Threat? Research, Access and Next Steps,’€ will be held on Thursday, March 14 at 1:30 p.m. at the Marriott Wardman Park Hotel. The conversation will be moderated by Karen Goraleski, Executive Director of the American...
Dear Research Advocate, Are we heading over the fiscal cliff? You have probably seen the several public opinion polls saying most Americans now think it’€™s inevitable. (’€œMerry Cliftmas,’€ says Jon Stewart.) Our latest polling tracks with that of others ’€” and adds a timely insight. Just when one might least expect Americans to voluntarily increase what they owe to Uncle Sam, more than 50% say they would be willing to pay $1 more per week if they were sure the dollars would go to medical research. See this finding and more in a new poll we commissioned to take the pulse of Americans at this high-stakes time in our history. We have been asking about willingness to pay more in taxes for...
On December 3, Policy Cures released its fifth annual G-FINDER report , a comprehensive survey of funding for research and development for neglected diseases. The report tracks global public, private and philanthropic investments into R&D for 31 diseases, including HIV/AIDS, tuberculosis, malaria and NTDs. In positive news, this year’€™s report shows that total funding has actually increased by $443 million since 2007. The report demonstrates that government funding, which accounts for over two-thirds of all investment, is increasingly going toward basic academic research, rather than product development. Research!America believes it is vital that the entire research pipeline be fully...

Sidebar Quote

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America